Greenwich LifeSciences, Inc.
General ticker "GLSI" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $144.3M (TTM average)
Greenwich LifeSciences, Inc. follows the US Stock Market performance with the rate: 36.4%.
Estimated limits based on current volatility of 4.9%: low 26.01$, high 28.66$
Factors to consider:
- Total employees count: 7 as of 2023
- Top business risk factors: Operational and conduct risks, Manufacturing disruptions, Cybersecurity threats, Strategic risks and growth management, Labor/talent shortage/retention
- Current price 60.0% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [6.99$, 17.76$]
- 2025-12-31 to 2026-12-31 estimated range: [5.91$, 15.42$]
Financial Metrics affecting the GLSI estimates:
- Negative: with PPE of -10.0 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -4.65 <= 0.01
- Positive: Investing cash flow per share per price, % of 0 > -0.63
- Positive: 42.68 < Shareholder equity ratio, % of 61.90 <= 64.29
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term GLSI quotes
Long-term GLSI plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $8.04MM | $9.33MM | $16.01MM |
| Operating Income | $-8.04MM | $-9.33MM | $-16.01MM |
| Non-Operating Income | $0.22MM | $0.44MM | $0.22MM |
| R&D Expense | $6.48MM | $7.70MM | $12.95MM |
| Income(Loss) | $-7.83MM | $-8.89MM | $-15.79MM |
| Profit(Loss)* | $-7.83MM | $-8.89MM | $-15.79MM |
| Stockholders Equity | $13.21MM | $6.70MM | $2.53MM |
| Assets | $13.48MM | $6.99MM | $4.09MM |
| Operating Cash Flow | $-6.20MM | $-6.48MM | $-7.27MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $-7.54MM | $0.00MM | $4.37MM |
| Earnings Per Share** | $-0.61 | $-0.69 | $-1.21 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.